Newsroom
What has happened so far
Approval and trial milestones, with press coverage. Each item links to the original article.
Press coverage
Whosaeng Shinbo
2026.06.16
(in Korean)
Digital therapeutic shows efficacy in patients with chronic knee pain
Confirmatory trial shows functional improvement in adults with chronic knee pain.
ZDNet Korea
2025.06.25
(in Korean)
MFDS approves confirmatory trial plan for SYM Healthcare’s 4DEYE DTx
MFDS approved the confirmatory trial protocol for the 4DEYE DTx digital therapeutic.
Electronic Times
2025.06.10
(in Korean)
SYM Healthcare’s digital therapeutic receives MFDS clinical trial approval
AVING
2025.05.27
(in Korean)
SYM Healthcare demos 4DEYE Dx musculoskeletal screening at 2025 Home Care, Rehabilitation and Welfare Exhibition
JoongAng Ilbo
2025
(in Korean)
SYM Healthcare’s AI musculoskeletal screening platform 4DEYE Dx certified as a Class II medical device
4DEYE Dx receives MFDS Class II medical device certification.
Daehan Geumyung Sinmun
2024.08.12
(in Korean)
SYM Healthcare selected for TIPS R&D, pushing AI rehabilitation therapeutic 4DEYE global
Links open the outlet’s site. Articles are in Korean; headlines are English summaries.
Insights
Stories on musculoskeletal health
What really happens in the knee, shoulder and lower back, from a clinical view (in Korean).
Visit the blog
On site
Exhibitions and installations
Trade show booths, hospital installations and team life, on Instagram.
Visit Instagram
Media inquiries
For press releases and images, email sales@symhc.co.kr.
Start putting numbers on movement
Clinics, sports, schools, workplaces or senior care: see a live demo and the operating terms.